Arsenic methylation and bladder cancer risk in case-control studies in Argentina and the United States
- PMID: 16688004
- DOI: 10.1097/01.jom.0000200982.28276.70
Arsenic methylation and bladder cancer risk in case-control studies in Argentina and the United States
Abstract
Objective: We sought to assess whether the metabolism of arsenic impacts a person's susceptibility to bladder cancer.
Methods: Urinary methylation products were measured in subjects from Argentina (114 cases and 114 controls) and the United States (23 cases and 49 controls).
Results: In Argentina, the adjusted odds ratio (OR) for subjects with a high proportion of ingested arsenic excreted as monomethylarsonate (%MMA) was 2.17 (95% confidence interval [CI] = 1.02-4.63) in smokers and 0.48 (95% CI = 0.17-1.33) in nonsmokers. In the United States, the adjusted ORs for high %MMA in subjects with arsenic intakes less than and greater than 100 microg/d were 1.20 (95% CI = 0.27-5.38) and 2.70 (95% CI = 0.39-18.6).
Conclusions: Overall, these results are consistent with data from Taiwan suggesting that some individuals who excrete a higher proportion of ingested arsenic as MMA are more susceptible to arsenic-related cancer.
Similar articles
-
Intraindividual variability in arsenic methylation in a U.S. population.Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):919-24. doi: 10.1158/1055-9965.EPI-04-0277. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15824164
-
Arsenic methylation and lung and bladder cancer in a case-control study in northern Chile.Toxicol Appl Pharmacol. 2014 Jan 15;274(2):225-31. doi: 10.1016/j.taap.2013.11.014. Epub 2013 Dec 1. Toxicol Appl Pharmacol. 2014. PMID: 24296302 Free PMC article.
-
Genetic polymorphisms in MTHFR 677 and 1298, GSTM1 and T1, and metabolism of arsenic.J Toxicol Environ Health A. 2007 Jan 15;70(2):159-70. doi: 10.1080/15287390600755240. J Toxicol Environ Health A. 2007. PMID: 17365577
-
Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses.Toxicology. 2014 Mar 20;317:17-30. doi: 10.1016/j.tox.2014.01.004. Epub 2014 Jan 21. Toxicology. 2014. PMID: 24462659 Review.
-
Arsenic metabolism and cancer risk: A meta-analysis.Environ Res. 2017 Jul;156:551-558. doi: 10.1016/j.envres.2017.04.016. Epub 2017 Apr 26. Environ Res. 2017. PMID: 28433864 Review.
Cited by
-
Toenail arsenic species and metallome profiles associated with breast, cervical, prostate, and skin cancer prevalence in the Atlantic Partnership for Tomorrow's Health cohort.Front Public Health. 2023 Jun 15;11:1148283. doi: 10.3389/fpubh.2023.1148283. eCollection 2023. Front Public Health. 2023. PMID: 37397723 Free PMC article.
-
Low-level determination of six arsenic species in urine by High Performance Liquid Chromatography-Inductively Coupled Plasma-Mass Spectrometry (HPLC-ICP-MS).Anal Methods. 2011 May 1;3(5):1122-1129. doi: 10.1039/c0ay00601g. Epub 2011 Mar 30. Anal Methods. 2011. PMID: 37020862 Free PMC article.
-
The Folic Acid and Creatine Trial: Treatment Effects of Supplementation on Arsenic Methylation Indices and Metabolite Concentrations in Blood in a Bangladeshi Population.Environ Health Perspect. 2023 Mar;131(3):37015. doi: 10.1289/EHP11270. Epub 2023 Mar 28. Environ Health Perspect. 2023. PMID: 36976258 Free PMC article. Clinical Trial.
-
Arsenicism by Chronic Exposure to Mine Tailings in Peru: An Analysis of 17 Cases with Lesions on Skin and/or Annexes.Clin Cosmet Investig Dermatol. 2022 Nov 8;15:2407-2414. doi: 10.2147/CCID.S378622. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 36387961 Free PMC article.
-
Arsenic Speciation and Metallomics Profiling of Human Toenails as a Biomarker to Assess Prostate Cancer Cases: Atlantic PATH Cohort Study.Front Public Health. 2022 Jul 7;10:818069. doi: 10.3389/fpubh.2022.818069. eCollection 2022. Front Public Health. 2022. PMID: 35875010 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
